Relic Pharma Limited - Company overview

Relic Pharma Limited was incorporated on 4 May 1995 and is registered with ROC Mumbai.

1995-05-04 Mumbai, Maharashtra Active Unlisted Active Compliant
Connect MCP

Key Metrics Public MCA facts are exact. Revenue, profit, assets, and employee figures may show as ranges until unlocked.

REVENUE
-
▼ -100.0%
FY 2023
PROFIT / LOSS
Loss · Under ₹1 Lakh
▼ -189.3%
FY 2023
EBITDA
Loss · Under ₹1 Lakh
▲ 24.5%
FY 2023
NET WORTH
₹10–50 Lakh
▼ -0.1%
FY 2023
TOTAL ASSETS
₹50 Lakh–1 Cr
▼ -0.1%
FY 2023
OPEN CHARGES
-
-
PAID-UP CAPITAL
1.00 cr
AUTHORISED CAPITAL
3.25 cr
COMPANY AGE
31 Years 6 Months
since 1995-05-04
LAST FILING WITH ROC
2024-03-31
Last AGM: 2024-08-19
ACTIVE GST
-
Updated: 2025-02-01 22:26:17
SATISFIED CHARGES
-
-

Company Health Scores Scores from 0–100 based on filings, compliance signals, financials, and board history on this profile.

Health scores for Relic Pharma Limited covering vendor trust, statutory compliance, financial health and director risk - derived from MCA filings, GST and EPFO records, financial statements and the company's board history.

Vendor Trust Score Moderate
72/100
Overall counterparty comfort for vendors and customers.
  • Blend of compliance (75), financial health (45), director (95) and company-foundation signals.
  • Operating for 31+ years.
Compliance Score Low risk
75/100
Statutory filings, status and regulatory flags.
  • Company status is Active as per MCA.
  • Last balance sheet filed for Mar 2024 - filings look overdue.
Financial Health Score High risk
45/100
Profitability, leverage and liquidity from filed statements.
  • Loss-making in FY 2023.
  • Positive net worth.
Director Risk Score Low risk
95/100
Board strength, DIN status and churn.
  • 3 directors on the board.
  • No disqualified or deactivated DINs on the current board.
Scores are derived from MCA filings, financial statements and public records on this page. Higher is safer. They are indicative, not a credit rating.
360° Intelligence Report: trust score, financial health, credit risk, growth & distress signals - auto-generated from filings. View report →

About Relic Pharma Limited Company identity, industry, contact, and registration details from MCA and company records.

Relic Pharma Limited was incorporated on 4 May 1995 and is registered with ROC Mumbai. It is an active public limited company, now more than 31 years old. The registered office is at J-Block Bhangwadi Shopping Centre Kalbadevi Road, Mumbai, Maharashtra.

In its MCA filings the main business is listed as other financial activities, which made up 100% of turnover.

It has three directors: Hemant Kantilal Choksey, Baijoo Madhusudan Raval and Uday Madhusudan Raval. The longest-serving is Baijoo Madhusudan Raval, on the board since 1995; the most recent to join is Hemant Kantilal Choksey, appointed in April 2014. Two former directors are on record; the most recent to leave was Madhusudan Mohanlal Raval in April 2014.

₹1 crore of its ₹3.25 crore authorised capital is paid up (about 31%). Its latest balance sheet on MCA is for the year ending 31 March 2024, and the last AGM was on 19 August 2024. Nothing newer than 2024 shows up here, so it is worth checking the MCA portal for later filings. No charges (secured loans) are registered against it.

Financial Services ••••••••
  • Location J-Block Bhangwadi Shopping Centre Kalbadevi Road, Mumbai, Maharashtra - 400002
Legal NameRelic Pharma Limited
CIN / LLPINU67120MH1995PLC088000
Company No.088000
ClassificationPublic Limited Indian Non-Government Company
Incorporation Date1995-05-04
Date of AGM2024-08-19
Date of Balance Sheet2024-03-31
Listing StatusUnlisted
ROC CodeRoc Mumbai
PAN
LEI Number
Active ComplianceActive Compliant

Current Directors of Relic Pharma Limited (3) Current board members from MCA filings, including designation and appointment details.

H
Director | Since 2014-04-19 | DIN: 00396961
B
Director | Since 1995-05-04 | DIN: 00429398
U
Director | Since 1995-05-04 | DIN: 00727294

Financial Performance of Relic Pharma Limited Bands and Low / Medium / High trend shape. Exact figures unlock with your report.

Estimated bands · FY 2023
Revenue - ▼ -100.0%
P&L Loss · Under ₹1 Lakh ▼ -189.3%
EBITDA Loss · Under ₹1 Lakh ▲ 24.5%
Net worth ₹10–50 Lakh ▼ -0.1%

Exact figures and labelled charts require an active report plan.

Verified entity values are shown only after access is granted.

Business Activity Principal business activity and turnover mix from MCA filings.

Activity GroupDescriptionTurnover %
Financial and insurance ServiceOther financial activities100
Financial and insurance ServiceOther financial activities100.00

Financial Ratios of Relic Pharma Limited Profitability, leverage, and liquidity ratios from filed statements. Exact values unlock with your report.

9 years of ratios on record

Profitability, leverage and liquidity ratios require an active report plan.

Net profit margin Debt / Equity Current ratio ROE

Unlock exact ratio values and multi-year insights.

Verified entity values are shown only after access is granted.

Shareholding Pattern of Relic Pharma Limited Ownership and contribution detail from filings. Full breakdown unlocks with your report.

6 shareholder categories on record

Ownership mix and contribution history require an active report plan.

Ownership mix Category breakdown Year-wise pattern Promoter holding

Unlock full ownership and contribution details.

Verified entity values are shown only after access is granted.

MSME Payment Delays by Relic Pharma Limited MSME supplier payment delays and filing history. Full amounts unlock with your report.

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

Outstanding amounts Delay periods and reasons MSME-1 filing history Vendor payment signals

MSME payment history requires an active report plan.

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Relic Pharma Limited Official MCA forms, returns, and filing index. Document access unlocks with your report.

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

Incorporation documents Annual returns and statements Charge filings Complete filing index

MCA filings and documents require an active report plan.

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Relic Pharma Limited Common questions about this company from MCA and profile data. Some answers are limited until unlocked.
Who is the owner of Relic Pharma Limited?
MCA does not publish an "owner" field. Relic Pharma Limited is run by its directors, Hemant Kantilal Choksey, Baijoo Madhusudan Raval and Uday Madhusudan Raval. The people who own the shares are listed in its annual return (form MGT-7), which can differ from the directors.
Who are the current board members and directors of Relic Pharma Limited?
Relic Pharma Limited has three current directors: Hemant Kantilal Choksey (since April 2014), Baijoo Madhusudan Raval (since May 1995) and Uday Madhusudan Raval (since May 1995).
What is CIN of Relic Pharma Limited?
The CIN of Relic Pharma Limited is U67120MH1995PLC088000. Reading it left to right: U means it is not listed, 67120 is the industry code it registered under, MH is Maharashtra, 1995 is the year it was registered, PLC is the company type and 088000 is its registration number.
When was Relic Pharma Limited incorporated?
Relic Pharma Limited was incorporated on 4 May 1995 with ROC Mumbai. That makes it more than 31 years old.
What is the registered address of Relic Pharma Limited?
The registered office on MCA records is J-Block Bhangwadi Shopping Centre Kalbadevi Road, Mumbai, Maharashtra - 400002.
What is the current status of Relic Pharma Limited?
MCA shows Relic Pharma Limited as Active, and its last AGM on record was in August 2024.
What is the contact number or email for Relic Pharma Limited?
You can post to its registered office at J-Block Bhangwadi Shopping Centre Kalbadevi Road, Mumbai, Maharashtra - 400002.
What industry or business activity is Relic Pharma Limited associated with?
Its MCA filings list the main business as other financial activities (100% of turnover).
What is paid-up capital and authorised share capital of Relic Pharma Limited?
Paid-up capital is ₹1 crore and authorised capital is ₹3.25 crore, so about 31% of the authorised amount has been issued.
When did Relic Pharma Limited last file accounts and hold an AGM?
The last AGM on record was on 19 August 2024, and the latest balance sheet is for the year ending 31 March 2024. Nothing newer than 2024 shows up, so check the MCA portal for later filings.
Where can I see charges and lenders for Relic Pharma Limited?
MCA shows no charges registered against Relic Pharma Limited, so no assets are pledged for a registered secured loan.
Have any directors left Relic Pharma Limited?
Yes, two former directors are on record. The most recent to leave were Madhusudan Mohanlal Raval (April 2014) and Narendra Ishwarlal Gandhi (May 2008).
What is the net worth of Relic Pharma Limited?
For FY 2023, the net worth of Relic Pharma Limited was in the ₹10–50 Lakh range.
How can I get the financial details of Relic Pharma Limited?
The latest accounts on record are for FY 2023. The Financial tab has year-wise profit and loss, balance sheet and ratios, with exact figures after you sign in.
Relic Pharma Limited - is it listed or unlisted?
Relic Pharma Limited is unlisted, so its shares are not traded on a stock exchange. Its CIN starts with U for the same reason.
What is the ROC code of Relic Pharma Limited?
Relic Pharma Limited is registered with ROC Mumbai.
What is the company classification of Relic Pharma Limited?
MCA classifies Relic Pharma Limited as: Public Limited Indian Non-Government Company.

Disclaimer: Data on this page is compiled from public sources as available in our system at the time of the last update and is for general information only. Scores are derived indicators, not credit ratings or advice - please verify from official sources and consult a professional before making any business or financial decision.